Matthew E Korenberg

CIK 1649903 · CFO, Treasurer · last filed 2026-06-05

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$13.37M

Companies

4

Total Filings

58

Lifetime Open-Market Net

-$12.53M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
LFCR Director 69,967 $5.64 $394.6K $0 3 2026-06-05
PVLA CFO, Treasurer $108.81 $0 3 2026-02-09
LGND President & COO 50,777 $255.54 $12.98M -$12.53M 50 2024-09-24
Qualigen Therapeutics, Inc. (QLGN) Delisted Director $3.21 $0 2 2022-08-04

Recent Filings · Page 4 of 6

58 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2021-07-02 LGND Other (J) +247 $21.2K EDGAR
2021-02-18 LGND Tax (F) −2,309 -$398.2K EDGAR
2021-02-05 LGND Grant (A) +10,819 $0 EDGAR
2021-01-27 LGND Mixed +4,997 -$329.3K EDGAR
2020-07-01 LGND Other (J) +238 $21.2K EDGAR
2020-06-08 Qualigen Therapeutics, Inc. (QLGN) Delisted Grant (A) $0 EDGAR
2020-04-24 LGND Tax (F) −1,166 -$140.9K EDGAR
2020-02-18 LGND Grant (A) +6,848 $0 EDGAR
2019-12-26 LGND Mixed +2,865 -$223.8K EDGAR
2019-09-23 LGND Buy (P) $0 EDGAR
Showing 3140 of 58
Page 4 of 6
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.